Low RAI2 expression is a marker of poor prognosis in breast cancer

被引：0
作者：
Sayaka Nishikawa
Yasuaki Uemoto
Tae-Sun Kim
Tomoka Hisada
Naoto Kondo
Yumi Wanifuchi-Endo
Takashi Fujita
Tomoko Asano
Yusuke Katagiri
Mitsuo Terada
Akiko Kato
Yu Dong
Hiroshi Sugiura
Katsuhiro Okuda
Hiroyuki Kato
Satoshi Osaga
Satoru Takahashi
Tatsuya Toyama
机构：
[1] Nagoya City University Graduate School of Medical Sciences,Department of Breast Surgery
[2] Nagoya City University Graduate School of Medical Sciences,Advanced Medicine
[3] Nagoya City University Graduate School of Medical Sciences,Department of Oncology, Immunology and Surgery
[4] Nagoya City University Graduate School of Medical Sciences,Department of Experimental Pathology and Tumor Biology
[5] Nagoya City University Hospital,Clinical Research Management Center
[6] Toyokawa City Hospital,Department of Breast and Endocrine Surgery
来源：
Breast Cancer Research and Treatment | 2021年 / 187卷
关键词：
Breast cancer; Retinoic acid-induced 2 (RAI2); Disseminated tumor cells (DTC);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：81 / 93
页数：12
相关论文
共 50 条
[21]   Low expression of BMPRIB indicates poor prognosis of breast cancer and is insensitive to taxane-anthracycline chemotherapy [J].
Dai, Kun ;
Qin, Fengxia ;
Zhang, Huikun ;
Liu, Xiaoli ;
Guo, Caixia ;
Zhang, Ming ;
Gu, Feng ;
Fu, Li ;
Ma, Yongjie .
ONCOTARGET, 2016, 7 (04) :4770-4784
[22]   Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer [J].
Mark R Pickard ;
Andrew R Green ;
Ian O Ellis ;
Carlos Caldas ;
Vanessa L Hedge ;
Mirna Mourtada-Maarabouni ;
Gwyn T Williams .
Breast Cancer Research, 11
[23]   LAMP1 expression is associated with poor prognosis in breast cancer [J].
Wang, Qingqing ;
Yao, Juan ;
Jin, Qin ;
Wang, Xudong ;
Zhu, Huijun ;
Huang, Fan ;
Wang, Wei ;
Qiang, Jianfeng ;
Ni, Qichao .
ONCOLOGY LETTERS, 2017, 14 (04) :4729-4735
[24]   Expression of chemerin correlates with a poor prognosis in female breast cancer patients [J].
El-Sagheer, Ghada ;
Gayyed, Mariana ;
Ahmad, Asmaa ;
Abd Ei-Fattah, Aliaa ;
Mohamed, Manar .
BREAST CANCER-TARGETS AND THERAPY, 2018, 10 :169-176
[25]   Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer [J].
Yao, Juan ;
Jin, Qin ;
Wang, Xu-dong ;
Zhu, Hui-jun ;
Ni, Qi-chao .
MEDICINE, 2017, 96 (25)
[26]   DHX32 expression is an indicator of poor breast cancer prognosis [J].
Wang, Meng ;
Zhang, Guojun ;
Wang, Yajie ;
Ma, Ruimin ;
Zhang, Limin ;
Lv, Hong ;
Fang, Fang ;
Kang, Xixiong .
ONCOLOGY LETTERS, 2017, 13 (02) :942-948
[27]   TENASCIN IN BREAST-CANCER DEVELOPMENT - IS EPITHELIAL TENASCIN A MARKER FOR POOR-PROGNOSIS [J].
YOSHIDA, T ;
ISHIHARA, A ;
HIROKAWA, Y ;
KUSAKABE, M ;
SAKAKURA, T .
CANCER LETTERS, 1995, 90 (01) :65-73
[28]   Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer [J].
Tilman D. Rachner ;
Sabine Kasimir-Bauer ;
Andy Goebel ;
Kati Erdmann ;
Oliver Hoffmann ;
Martina Rauner ;
Lorenz C. Hofbauer ;
Rainer Kimmig ;
Ann-Kathrin Bittner .
Journal of Cancer Research and Clinical Oncology, 2021, 147 :2233-2238
[29]   Decreased expression of stomatin predicts poor prognosis in HER2-positive breast cancer [J].
Chin-Yau Chen ;
Chih-Yung Yang ;
Yen-Chung Chen ;
Chia-Wen Shih ;
Su-Shun Lo ;
Chi-Hung Lin .
BMC Cancer, 16
[30]   Decreased expression of stomatin predicts poor prognosis in HER2-positive breast cancer [J].
Chen, Chin-Yau ;
Yang, Chih-Yung ;
Chen, Yen-Chung ;
Shih, Chia-Wen ;
Lo, Su-Shun ;
Lin, Chi-Hung .
BMC CANCER, 2016, 16
12345